A phase II trial of docetaxel alone and in combination with gefitinib as second-line chemotherapy for patients with non-small cell Lung cancer: interim results from Groupe Francais de Pneumo-Cacerologie
ANNALS OF ONCOLOGY（2004）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要